Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trial simulation in drug development.

P L Bonate1

  • 1Quintiles, Clinical Pharmacokinetics, Kansas City, Missouri 64134, USA. pbonate@qkan.quintiles.com

Pharmaceutical Research
|May 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What happened to the modeling and simulation revolution?

Clinical pharmacology and therapeutics·2014
Same author

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.

The AAPS journal·2012
Same author

Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response.

British journal of clinical pharmacology·2007
Same author

A brief introduction to Monte Carlo simulation.

Clinical pharmacokinetics·2001
Same author

Prospective allometric scaling: does the emperor have clothes?

Journal of clinical pharmacology·2000
Same author

Rank power of metrics used to assess QTc interval prolongation by clinical trial simulation.

Journal of clinical pharmacology·2000
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026
See all related articles

Clinical trial simulation uses existing technologies to enhance drug development. This approach maximizes trial success, reduces costs, and potentially shortens timelines by synthesizing drug information.

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Biostatistics and Clinical Trial Design

Background:

  • Drug development is a costly and lengthy process with a high failure rate.
  • Maximizing information content from clinical trials is crucial for success.
  • Existing technologies can be applied to optimize clinical trial strategies.

Purpose of the Study:

  • To introduce clinical trial simulation as a method to improve drug development.
  • To discuss the potential benefits and applications of simulation in pharmaceutical research.
  • To review relevant literature and provide recommendations for simulation implementation.

Main Methods:

  • Application of established simulation techniques, such as Monte Carlo simulation.
  • Synthesizing high-quality drug information to inform trial design.

Related Experiment Videos

  • Utilizing simulation to predict and enhance clinical trial outcomes.

    • Main Results:

    • Simulation offers a pathway to increase the information yield from drug development.
    • Potential for reducing the number of required clinical studies.
    • Improved probability of clinical trial success and possible reduction in development time.

    Conclusions:

    • Clinical trial simulation presents a valuable tool for pharmaceutical companies.
    • It can lead to significant cost reductions and improved efficiency in drug development.
    • Careful consideration and recommendations are necessary for effective use of simulation.